TGR-1202 (Umbralisib) in Treatment Naïve Patients With Chronic Lymphocytic Leukemia (CLL)

Clinical trial NCT04163718 · TERMINATED

Trial details

NCT number: NCT04163718
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia

Start date: 2019-11-12
Primary completion: 2022-10-19
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.